🇺🇸 FDA
Patent

US 11162096

Methods for modulating expression of C9ORF72 antisense transcript

granted A61PA61P21/00A61P25/28

Quick answer

US patent 11162096 (Methods for modulating expression of C9ORF72 antisense transcript) held by The Regents of the University of California expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P21/00, A61P25/28